EIF3B and gastric adenocarcinoma: Cell proliferation, migration, and invasion are inhibited when EIF3B is down-regulated in cells of OV, STAD (gastric cancer), NSLC (non-small cell lung cancer), ESCC (esophageal squamous cell carcinoma), and ccRCC (clear cell renal cell carcinoma) [41–45].